PMID-34267654 – Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Seiwerth S, Milavic M, Vukojevic J, Gojkovic S, Krezic I, Vuletic LB, Perpic AK, Perovic D, Sikiric P et al. "Stable Gastric Pentadecapeptide BPC 157 and Wound Healing," Frontiers in Pharmacology, 2021;12:627533. doi:10.3389/fphar.2021.627533
Quick Reference
| Property | Value |
|---|---|
| PMID | 34267654 |
| DOI | 10.3389/fphar.2021.627533 |
| Year | 2021 |
| Journal | Frontiers in Pharmacology |
| Study Type | Narrative Review |
| Evidence Level | V |
| Sample | Review of preclinical studies across multiple wound models |
| Peptide(s) Studied | BPC-157 |
Key Findings
- Comprehensive review of BPC 157's wound healing properties across skin wounds, diabetic ulcers, deep burns, and various tissue defects
- BPC 157 resolves vessel constriction, stabilizes platelet plugs, and promotes clot dissolution in wound healing
- Rapid upregulation of multiple genes involved in the healing cascade including growth factors and extracellular matrix proteins
- Effective across both topical and systemic (SubQ, IP, oral) administration routes
- Demonstrated efficacy in compromised healing conditions (diabetes, corticosteroid use)
- Seiwerth as first author with Sikiric group collaboration
Study Design
Narrative review synthesizing preclinical evidence from the Sikiric/Seiwerth group and others. Covers multiple wound models including skin incisions, burns, diabetic wounds, and fistulas. Reviews both the molecular mechanisms and functional outcomes.
Limitations
- Predominantly reviews preclinical data; limited human evidence discussed
- Majority of cited studies originate from the Sikiric/Seiwerth research group (single-group concern)
- Published in Frontiers in Pharmacology, which has variable peer review quality
- No systematic methodology; narrative review format
Clinical Relevance
Provides a comprehensive overview of BPC 157's wound healing mechanisms that spans multiple tissue types. The breadth of wound models showing benefit is noteworthy, but translation to human clinical practice requires controlled trials. Particularly relevant for practitioners considering BPC-157 for wound healing, post-surgical recovery, or diabetic complications.
Related
#research #narrative-review #evidence-level-V